Dragica Tomin

Is there a “gold” standard treatment for patients with isolated myeloid sarcoma?

Darko Antić, Ivo Elezović, Nataša Milić et al. · Biomedicine & Pharmacotherapy · 2012 · 102 citations

Hematological Malignancy, Systemic Treatment, Medicine +4

International Society of Thrombosis and Hemostasis Scoring System for disseminated intravascular coagulation ≥6: a new predictor of hemorrhagic early death in acute promyelocytic leukemia

Mirjana Mitrović, Nada Suvajdžić, Andrija Bogdanović et al. · Medical Oncology · 2013 · 78 citations

Thrombosis, Cardiovascular Disease, Hematology +8

Clinical significance of genetic aberrations in secondary acute myeloid leukemia

Jelena D. Milosevic Feenstra, Ana Puda, Luca Malcovati et al. · American Journal of Hematology · 2012 · 77 citations · Full text

Mixed-phenotype Acute Leukemia, Genetics, Genetic Epidemiology +18

Thrombotic events in acute promyelocytic leukemia

Mirjana Mitrović, Nada Suvajdžić, Ivo Elezović et al. · Thrombosis Research · 2014 · 68 citations

Hematological Malignancy, Thrombosis, Mixed-phenotype Acute Leukemia +6

Mycophenolate mophetil therapy for chronic immune thrombocytopenic purpura resistant to steroids, immunosuppressants, and/or splenectomy in adults

Milica C̆olović, Nada Suvajdžić, Nataša Čolović et al. · Platelets · 2010 · 32 citations